These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9336992)

  • 21. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring decisional certainty among women seeking abortion.
    Ralph LJ; Foster DG; Kimport K; Turok D; Roberts SCM
    Contraception; 2017 Mar; 95(3):269-278. PubMed ID: 27745910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taking neuroleptic medications as the treatment for schizophrenia: A phenomenological study.
    Usher K
    Aust N Z J Ment Health Nurs; 2001 Sep; 10(3):145-55. PubMed ID: 11493286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insight in schizophrenia. Its relationship to acute psychopathology.
    McEvoy JP; Apperson LJ; Appelbaum PS; Ortlip P; Brecosky J; Hammill K; Geller JL; Roth L
    J Nerv Ment Dis; 1989 Jan; 177(1):43-7. PubMed ID: 2562850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs.
    Yang YK; Tarn YH; Wang TY; Liu CY; Laio YC; Chou YH; Lee SM; Chen CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):385-94. PubMed ID: 16048443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosaging patterns in schizophrenia with depot, oral and combined neuroleptic therapy.
    Remington GJ; Prendergast P; Bezchlibnyk-Butler KZ
    Can J Psychiatry; 1993 Apr; 38(3):159-61. PubMed ID: 8098988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug compliance and health locus of control in schizophrenia].
    Combes C; Feral F
    Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptics, subjective perception and quality of life.
    Eranti S; Chaturvedi SK
    Acta Psychiatr Scand; 1998 Aug; 98(2):165-6. PubMed ID: 9718244
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
    Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
    J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health beliefs and compliance with antipsychotic medication.
    Budd RJ; Hughes IC; Smith JA
    Br J Clin Psychol; 1996 Sep; 35(3):393-7. PubMed ID: 8889080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depot neuroleptics, schizophrenia and the role of the nurse: is practice evidence based? A review of the literature.
    Marland GR; Sharkey V
    J Adv Nurs; 1999 Dec; 30(6):1255-62. PubMed ID: 10583634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia.
    Achtyes E; Simmons A; Skabeev A; Levy N; Jiang Y; Marcy P; Weiden PJ
    BMC Psychiatry; 2018 Sep; 18(1):292. PubMed ID: 30223804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What information do patients with schizophrenia have about their illness and treatment?].
    Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
    Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.
    Samalin L; Garnier M; Auclair C; Llorca PM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decision-making Capacity for Treatment of Psychotic Patients on Long Acting Injectable Antipsychotic Treatment.
    Nystazaki M; Pikouli K; Tsapakis EM; Karanikola M; Ploumpidis D; Alevizopoulos G
    Arch Psychiatr Nurs; 2018 Apr; 32(2):300-304. PubMed ID: 29579528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Psychoeducation on Knowledge of and Attitude Toward Medications in Clients With Schizophrenia and Schizoaffective Disorders.
    Choe K; Sung BJ; Kang Y; Yoo SY
    Perspect Psychiatr Care; 2016 Apr; 52(2):113-9. PubMed ID: 25640073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choosing antipsychotic maintenance therapy--a naturalistic study.
    Tavcar R; Dernovsek MZ; Zvan V
    Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.